etravirine has been researched along with casein kinase ii in 1 studies
Studies (etravirine) | Trials (etravirine) | Recent Studies (post-2010) (etravirine) | Studies (casein kinase ii) | Trials (casein kinase ii) | Recent Studies (post-2010) (casein kinase ii) |
---|---|---|---|---|---|
572 | 90 | 321 | 3,268 | 5 | 1,299 |
Protein | Taxonomy | etravirine (IC50) | casein kinase ii (IC50) |
---|---|---|---|
Serine/threonine-protein kinase Sgk1 | Homo sapiens (human) | 3.57 | |
Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 0.484 | |
Casein kinase II subunit alpha | Rattus norvegicus (Norway rat) | 0.14 | |
Casein kinase II subunit alpha' | Homo sapiens (human) | 2.23 | |
Cyclin-A2 | Homo sapiens (human) | 2.38 | |
Cyclin-dependent kinase 2 | Homo sapiens (human) | 2.38 | |
Casein kinase II subunit beta | Homo sapiens (human) | 2.23 | |
Casein kinase II subunit beta | Rattus norvegicus (Norway rat) | 0.14 | |
Casein kinase II subunit alpha | Homo sapiens (human) | 2.23 | |
Cyclin-A1 | Homo sapiens (human) | 2.38 | |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | 0.26 | |
Casein kinase II subunit alpha 3 | Homo sapiens (human) | 0.14 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abdelrahman, M; Almadani, SA; ALsiyud, DF; Alzain, AA; Ashour, A; Ghazawi, KF; Ibraheem, W; Ibrahim, SRM; Miski, SF; Mohamed, GA; Osman, W; Sherif, AE; Shoaib, TH | 1 |
1 other study(ies) available for etravirine and casein kinase ii
Article | Year |
---|---|
Exploring the potential of approved drugs for triple-negative breast cancer treatment by targeting casein kinase 2: Insights from computational studies.
Topics: Antineoplastic Agents; Casein Kinase II; Drug Approval; Female; Humans; Molecular Docking Simulation; Treatment Outcome; Triple Negative Breast Neoplasms | 2023 |